| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a71caf66bd467412cc746f6147db0025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94098ef74d16ec18d671c18f82e4fd6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25c607e8029b426734a4d7efc1125e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b3bfa13c3c3f58f8c49762082bd75e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2558b087ae86f5cf601d651e5d5b317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e60df290caaf9d612758e01f8ae697
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df799089ad1ec3da1aedc42f799be0f |
| publicationDate |
2022-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4054647-A1 |
| titleOfInvention |
Anti-cd30 antibody-drug conjugates and their use for the treatment of hiv infection |
| abstract |
The disclosure provides anti-CD30 antibody-drug conjugates and methods of using the same to increase CD4+T-cell lymphocyte count or treat l-IIV infection. The disclosure also provides articles of manufacture or kits comprising said antibody drug-conjugates that bind to CD30 for increasing CD4+T-cell lymphocyte count or treating HIV infection. |
| priorityDate |
2019-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |